Pulling SEC filings + quote and writing the call…

Cingulate Inc.
Next earnings ≈ Aug 13, 2026 · est. from filing cadence
Last earnings -10.8% on 2026-05-14
High leverage (liabilities/equity 5.0x).
Cingulate Inc. shows limited reported revenue, and -894.8% ROE.
| Line item | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | — | — | — | — | — |
| Gross profit | — | — | — | — | — |
| Operating income | -$20.7M | -$17.5M | -$22.8M | -$15.6M | -$19.9M |
| Net income | -$20.7M | -$17.7M | -$23.5M | -$16.6M | -$22.4M |
| Diluted EPS | — | -$29.35 | -$311.99 | -$10.86 | -$4.44 |
| Net margin | — | — | — | — | — |
Annual figures from SEC 10-K XBRL filings. Open the filing links below for full statement detail.
Computed from SEC XBRL annual figures + the current quote. EV and ROIC use long-term + current debt where filed; estimates, not investment advice.
Sources: SEC EDGAR (CIK 0001862150, latest 10-Q filed 2026-05-14) · EODHD · as of 6/26/2026, 7:27:16 PM.
Research and education only — not financial advice. EDGAR is not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities EDGAR rates; see Disclosures. Past performance does not guarantee future results. Do your own research.
| 2026-03-09 | Silva Raul R. EVP and CSO | Award | 4.53K | |
| 2026-03-09 | Silva Raul R. EVP and CSO | Tax | 1.83K | |
| 2026-03-09 | Schaffer Shane J. Chief Executive Officer | Award | 6.86K | |
| 2026-03-09 | Schaffer Shane J. Chief Executive Officer | Tax | 2.96K | |
| 2026-03-09 | Callahan Jennifer L. EVP and CFO | Award | 15.3K | |
| 2026-03-09 | Callahan Jennifer L. EVP and CFO | Tax | 6.43K | |
| 2026-03-09 | Patel Nilay Dahyabhai EVP, CLO and CCO | Award | 5.47K | |
| 2026-03-09 | Patel Nilay Dahyabhai EVP, CLO and CCO | Tax | 2.09K | |
| 2026-03-09 | Brams Matthew EVP and Chief Medical Officer | Award | 4.53K | |
| 2026-03-09 | Brams Matthew EVP and Chief Medical Officer | Tax | 1.02K | |
| 2026-02-13 | Hargroves Thomas Jeffrey Director | Buy | 97.3K @ $5.04 | $490K |
| 2026-02-06 | Werth Peter J. Director | Buy | 19.5K @ $5.04 | $98.1K |
Dates from 8-K (Item 2.02); beat/miss = reported EPS vs consensus (Finnhub, recent quarters); move = prior close → close on/after.
1044 tracked peers · median
Recent news tone vs the market's typical (which skews positive). A soft signal, not a recommendation.